Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11527 posts found.

GSK licences RA drug

June 5, 2013 Research and Development, Sales and Marketing GSK, RA, morphosys

GlaxoSmithKline is gambling millions of euros on an investigational drug in a bid to get an edge in the fight …
News

AstraZeneca abandons late-stage RA drug

June 5, 2013 Research and Development, Sales and Marketing AstraZeneca, RA, Rigel

AstraZeneca is to exit development of a new rheumatoid arthritis drug, after Phase III trials produced disappointing results.The Anglo-Swedish firm …
News

AstraZeneca/BMS drug granted speedy FDA review

June 5, 2013 Sales and Marketing AstraZeneca, BMS, lipodystrophy

AstraZeneca and partner Bristol-Myers Squibb have been granted a priority review for their rare disease drug metreleptin. The medicine is …
News

Sanofi admits $285m failure

June 4, 2013 Research and Development, Sales and Marketing Sanofi, its benzamide iniparib, otamixaban

Sanofi has consigned two investigational drugs to the corporate dustbin, preferring a $285 million dent in its coffers to continuing …
News

NSCLC lift for Boehringer

June 4, 2013 Research and Development, Sales and Marketing Boehringer, NSCLC

Boehringer’s pipeline has been boosted with the news that its investigational oral triple angiokinase inhibitor nintedanib plus chemotherapy, extends the …
News

Vocera appoints president and chief executive

June 4, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Brent Lang, Vocera

Healthcare comms firm Vocera Communications has announced Brent Lang’s appointment as president and chief executive officer to the firm and …
Appointment

UK government cautious on trial transparency

June 4, 2013 Research and Development, Sales and Marketing Goldacre, UK, alltrials, transparency

Two ministers with responsibility for life sciences in the UK struck a cautious note over clinical trial transparency at an …
News

Promising signs for Novartis’ lung cancer drug

June 4, 2013 Sales and Marketing ALK+, ASCO, LDK378, NSCLC, Novartis

Targeted lung cancer treatment LDK378 has been shown to help patients with the ALK+ gene mutation in a phase I trial.Novartis’ drug …
News

Sinovac appoints chief financial officer

June 3, 2013 Manufacturing and Production, Research and Development, Sales and Marketing China, Sinovac

China-based biopharma products provider Sinovac Biotech has appointed vice president Nan Wang to be its chief financial officer. Previous CFO …
Appointment

Europe votes yes on greater trial transparency

June 3, 2013 Research and Development, Sales and Marketing Europe, Goldacre, alltrials, transparency

Europe has taken one step closer to increasing clinical trial transparency on the continent after MEPs voted yes on new …
News

Lilly and Roche back US research institute

May 31, 2013 Research and Development, Sales and Marketing Roche, lilly, notre dame, research

Eli Lilly and Roche Diagnostics are among the key backers of a $360 million US life sciences research facility which …
News

NICE green light for Eylea

May 31, 2013 Sales and Marketing Bayer, NICE, Regeneron

NICE has recommended Bayer’s injection Eylea as a treatment for neovascular (wet) age-related macular degeneration (AMD) if the manufacturer offers …
News

AstraZeneca and CRUK partner on drug trial

May 31, 2013 Sales and Marketing AstraZeneca, CRUK

AstraZeneca is partnering with Cancer Research UK to develop a new oncology medicine that targets a number of different cancers. …
News

Avillion appoints chief business officer

May 31, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion

Venture capitalist firm Avillion has announced the expansion of its leadership team with the appointment of Ramani Varanasi as chief …
Appointment

Bad pharma, good pharma: an insider’s view

May 30, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy

Most people in the pharmaceutical industry, particularly in the UK, will be well-acquainted with Ben Goldacre by now. He published his …
Feature
The Gateway to Local Adoption Series

Latest content

Scots neonatal innovations target hearing loss and earlier care

August 28, 2026

FDA grants De Novo authorisation to light-filtering device for migraine

August 28, 2026

Southgate opens Innovation Lab for logistics and fulfilment development

August 27, 2026

Bioptimus partners with Cancer Research Horizons to expand AI cancer data set

August 27, 2026

Agentis Health Group acquires Clinical Pharmacist Solutions

August 26, 2026